Leuna Demo Plant Global Bioenergies and Linde to Complete Basic Engineering

Editor: M.A. Manja Wühr

Converting sugars into the gaseous hydrocarbon isobutene: Global Bioenergies reaches milestone on the way to the commercialization of this biotechnological process and complete together with Linde the basic engineering of the demo plant in Leuna.

Related Vendors

The demo plant will be installed in the Fraunhofer CBP building at the Leuna complex.
The demo plant will be installed in the Fraunhofer CBP building at the Leuna complex.
(Picture: Fraunhofer-Zentrum CBP/Gunter Binsack)

Leuna/Germany – In February 2014, Global Bioenergies entrusted the Engineering Division of technology company The Linde Group with the mission to deliver the basic engineering study upstream of the construction of its demonstration plant. Recently, the two companies are glad to announce that this phase has been completed successfully.

Markus Wolperdinger, Vice President Biotechnology Plants at Linde's Engineering Division said: "We are proud to deliver to Global Bioenergies a complete basic engineering package for its process to convert sugars into isobutene, a gaseous hydrocarbon. This one-of-a-kind demo plant will be an important milestone on the way to the commercialization of Global Bioenergies' innovative biotechnological processes".

Demo Plant to be Installed at Fraunhofer CBP

Rick Bockrath, VP chemical engineering at Global Bioenergies, added: "We are now ready to move on to the next phase of the project, dedicated to the construction and exploitation of the demo plant."

The demo plant, expected to be installed in the Fraunhofer CBP building at the Leuna complex, is associated with a EUR 5.7 million grant from the German Federal Ministry of Research (BMBF).

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy.

Unfold for details of your consent

(ID:43270275)